leadf
logo-loader
viewMaxCyte Inc

MaxCyte Inc - Proactive One2One Virtual Event

MaxCyte Inc's (LON:MXCT) Doug Doerfler speaks to investors at the Proactive One2One Virtual Event. They're a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. For more information visit www.maxcyte.com

Quick facts: MaxCyte Inc

Price: 980 GBX

AIM:MXCT
Market: AIM
Market Cap: £828.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MaxCyte Inc named herein, including the promotion by the Company of MaxCyte Inc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

MaxCyte report 'extraordinary first half' with revenue 30% higher than same...

Maxcyte Inc's (LON:MXCT) Doug Doerfler talks to Proactive London about their full-year revenues which are on track to be 'slightly above' current market expectations. Doerfler discusses what he describes as an 'extraordinary first half' with half year revenue 30% higher than the same period...

on 1/10/20

2 min read